Douglas Hughes

Douglas Hughes

Director/Board Member at IMMUNOVANT, INC.

Net worth: 4 M $ as of 30/05/2026

64 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Douglas Hughes is currently Director at Immunovant Sciences Ltd. since 2019, Independent Director at Immunovant, Inc. since 2019, Chief Financial Officer & Director at Calyxo, Inc. since 2018, and Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former roles include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/04/2026 134,653 ( 0.07% ) 4 M $ 30/05/2026

Douglas Hughes active positions

CompaniesPositionStart
IMMUNOVANT, INC. Director/Board Member 17/12/2019
Director of Finance/CFO 31/12/2018
Director/Board Member 30/09/2019
Director of Finance/CFO 31/12/2017

Former positions of Douglas Hughes

CompaniesPositionEnd
EARGO, INC. Director/Board Member 06/12/2022
Director of Finance/CFO 31/12/2017
Public Communications Contact 31/03/2011
Director of Finance/CFO 31/12/2010
Director of Finance/CFO 31/12/2009
See the detail of Douglas Hughes's experience

Training of Douglas Hughes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

16

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Distribution Services

Industrial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Douglas Hughes